g. Information on the Cancer-Causing Properties and the Effects on the
Reproductive System of the Drug or Drug Class.
h. Tolerance and Dependency Risks Associated with the Drug or Drug Class.
i. The Name and Address of the Manufacturer, Distributor, or Dispenser of the
Drug or Drug Class.
j. The Date of the Last Revision of the PPI.
2-14